´ëÇѽŰæÁ¤½ÅÀÇÇÐȸ 2021³âµµ Ãá°èÇмú´ëȸ&PRCP 2021 : 2021-04-09±³À°ÀÏÀÚ : 2021-04-09
±³À°Àå¼Ò : ¿Â¶óÀÎ&¿ÀÇÁ¶óÀÎ µ¿½Ã °³ÃÖ ¿¬¼ö±³À° (¿ÀÇÁ¶óÀÎ:½ºÀ§½º±×·£µåÈ£ÅÚ ÄÁº¥¼Ç¼¾ÅÍ)
±³À°ÁÖÁ¦ :
(¿Â¶óÀΡ¤¿ÀÇÁ¶óÀÎ º´Çà) ´ëÇѽŰæÁ¤½ÅÀÇÇÐȸ 2021³âµµ Ãá°èÇмú´ëȸ&PRCP 2021 ÁÖÃÖ±â°ü : ´ëÇѽŰæÁ¤½ÅÀÇÇÐȸ
´ã´çÀÚ : ÀÌÁöÀ±
¿¬¶ôó : 02-3452-7213
À̸ÞÀÏ :
prcp2021@insession.co.kr ±³À°Á¾·ù : Á¤½Å°Ç°ÀÇÇаú
Âü¼®¿¹»óÀοø : 1000¸í
Èñ¸ÁÆòÁ¡ : 6Á¡ (ÀÏ¹Ý 4Á¡ / Çʼö 2Á¡)
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 46 ½Ã°£ 35ºÐ
¼¼ºÎ¼ö°·á : 230,000¿ø
ºñ°í [KNPAÃá°èÇмú´ëȸ]ȸ¿ø 120,000¿ø / ÀϹÝȸ¿ø(Àü°øÀÇ)¡¤ºñȸ¿ø(Á¤½Å°Ç°°ü·Ã ±Ù¹«ÀÚ, Çлý) 70,000¿ø / Ÿ°ú 140,000¿ø[PRCP2021]ȸ¿ø 150,000¿ø / ÀϹÝȸ¿ø(Àü°øÀÇ)¡¤ºñȸ¿ø(Á¤½Å°Ç°°ü·Ã ±Ù¹«ÀÚ, Çлý) 85,000¿ø / Ÿ°ú 170,000¿ø[PRCP2021+KNPAÃá°èÇмú´ëȸ]ȸ¿ø 200,000¿ø / ÀϹÝȸ¿ø(Àü°øÀÇ)¡¤ºñȸ¿ø(Á¤½Å°Ç°°ü·Ã ±Ù¹«ÀÚ, Çлý) 110,000¿ø / Ÿ°ú 230,000¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 04-09 Emerald Hall B (3F) 09:00~09:20 ºÒ¾È°ú ¿ì¿ïÀÇ °æ°è ÃÖ°ü¿ì(°í·ÁÀÇ´ë)
±³À°½Ã°£ 04-09 Emerald Hall B (3F) 09:20~09:40 ºÒ¾ÈÀå¾Ö, À¯ÀüÀû ¼ÒÀÎÀ¸·Î ¾îµð±îÁö ¼³¸í °¡´ÉÇÑ°¡? ¹ÚõÀÏ(Â÷ÀÇ°úÇдë)
±³À°½Ã°£ 04-09 Emerald Hall B (3F) 09:40~10:00 ³ú¿µ»ó ºòµ¥ÀÌÅÍ, ¿ì¸®¿¡°Ô ¹«¾ùÀ» ¾Ë·ÁÁÖ³ª? À±Á¦¿¬(¼¿ïÀÇ´ë)
±³À°½Ã°£ 04-09 Emerald Hall B (3F) 10:00~10:20 ºÒ¾ÈÀå¾Ö Ä¡·áÀÇ »õ·Î¿î ´ë¾È ±èÁØÇü(°í·ÁÀÇ´ë)
±³À°½Ã°£ 04-09 Emerald Hall B (3F) 10:20~10:30 ÁúÀÇ ÀÀ´ä ()
±³À°½Ã°£ 04-09 Diamond Hall (3F) 09:00~09:20 Opioid analgesics õ¿µÈÆ(ÀÎõÂü»ç¶ûº´¿ø)
±³À°½Ã°£ 04-09 Diamond Hall (3F) 09:20~09:40 Diet pills ±èÇöÁø(Ãæ³²ÀÇ´ë)
±³À°½Ã°£ 04-09 Diamond Hall (3F) 09:40~10:00 Benzodiazepines Á¤Á¶Àº(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 04-09 Diamond Hall (3F) 10:00~10:20 Non-benzodiazepine sleep medications À±Áö¾Ö(À»ÁöÀÇ´ë)
±³À°½Ã°£ 04-09 Diamond Hall (3F) 10:20~10:30 ÁúÀÇ ÀÀ´ä ()
±³À°½Ã°£ 04-09 Diamond Hall (3F) 10:30~11:30 ÀÌÇØ»óÃæ°ü¸® ÀåÇüÀ±(¾ÆÁÖÀÇ´ë)
±³À°½Ã°£ 04-09 Diamond Hall (3F) 11:30~12:30 Á¤½Å°Ç°º¹Áö¹ý ´Ù½Ãº¸±â ½Å±Çö(¼¿ï½Ã¸³´ë ¹ýÇаú)
±³À°½Ã°£ 04-09 Emerald Hall B (3F) 11:00~11:20 KMAP-DD ÀÇ °³¹ß ¹è°æ ¹× ¾Ë°í¸®µëÀÇ º¯Ãµ»ç Àå½ÂÈ£(¿ø±¤ÀÇ´ë)
±³À°½Ã°£ 04-09 Emerald Hall B (3F) 11:20~11:40 KMAP-DD 2021 – ÁÖ¿ä¿ì¿ï»ðÈÀÇ ¾à¹°Ä¡·á ¿ì¿µ¼·(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 04-09 Emerald Hall B (3F) 11:40~12:00 KMAP-DD 2021 – È¥À缺 ¾ç»ó°ú Ä¡·á ÀúÇ×¼º ¿ì¿ïÁõ, ±×¸®°í ºñ¾à¹°ÇÐÀû »ý¹°ÇÐÀû Ä¡·á ¹Ú¿µ¹Î(ÀÎÁ¦ÀÇ´ë)
±³À°½Ã°£ 04-09 Emerald Hall B (3F) 12:00~12:20 KMAP-DD 2021 – Special population ½É¼¼ÈÆ(¼øõÇâÀÇ´ë)
±³À°½Ã°£ 04-09 Emerald Hall B (3F) 12:20~12:30 ÁúÀÇ ÀÀ´ä ()
±³À°½Ã°£ 04-09 Emerald Hall B (3F) 14:00~14:20 ÀÚ»ì, ÀÚÇØ ¿ì·Á°¡ Àִ ȯÀÚ ¹éÁ¾¿ì(°æÈñÀÇ´ë)
±³À°½Ã°£ 04-09 Emerald Hall B (3F) 14:20~14:40 °ø°ÝÀûÀΠȯÀÚ Àӿ쿵(°Ç¾çÀÇ´ë)
±³À°½Ã°£ 04-09 Emerald Hall B (3F) 14:40~15:00 Ä¡·á¿¡ ºñ¼øÀÀÀûÀΠȯÀÚ ÇÏÁöÇö(°Ç±¹ÀÇ´ë)
±³À°½Ã°£ 04-09 Emerald Hall B (3F) 15:00~15:20 º¸»ó ¹®Á¦°¡ °É¸° ȯÀÚ ½Åö¹Î(°í·ÁÀÇ´ë)
±³À°½Ã°£ 04-09 Emerald Hall B (3F) 15:20~15:30 ÁúÀÇ ÀÀ´ä ()
±³À°½Ã°£ 04-09 Diamond Hall (3F) 14:00~14:20 Ç÷¾×À¸·Î ¾ËÃ÷ÇÏÀ̸Ӻ´ Áø´Ü ±è»óÀ±(ºÐ´ç¼¿ï´ëº´¿ø ½Å°æ°ú)
±³À°½Ã°£ 04-09 Diamond Hall (3F) 14:20~14:40 ³úÆÄ·Î ¾ËÃ÷ÇÏÀ̸Ӻ´ Áø´Ü °½Â¿Ï(¼¿ï´ëÇб³ °£È£Çаú)
±³À°½Ã°£ 04-09 Diamond Hall (3F) 14:40~15:00 ħÀ¸·Î ¾ËÃ÷ÇÏÀ̸Ӻ´ Áø´Ü ·ùÁøÇù(¹ÙÀÌ¿À¿ÀÄɽºÆ®¶ó ´ëÇ¥ÀÌ»ç)
±³À°½Ã°£ 04-09 Diamond Hall (3F) 15:00~15:20 MRI·Î ¾ËÃ÷ÇÏÀ̸Ӻ´ Áø´Ü ÀÓÇö±¹(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 04-09 Diamond Hall (3F) 15:20~15:30 ÁúÀÇ ÀÀ´ä ()
±³À°½Ã°£ 04-09 Emerald Hall B (3F) 16:00~16:25 Esketamine and Biological Mechanisms of Action for MDD and Major Depression with Suicidal Ideation ÀüÈ«Áø(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 04-09 Emerald Hall B (3F) 16:25~16:50 Transcutaneous Electrical Stimulation in Neuropsychiatric Disease for Electroceutical: Toward Remotely-supervised Treatment ±èµ¿Çö(´º·ÎÇÍ ÁÖ½Äȸ»ç CTO)
±³À°½Ã°£ 04-09 Emerald Hall B (3F) 16:50~17:15 Stem Cell Therapy for Treatment of Alzheimer¡¯s Disease: Prospects and Obstacles ¿Õ¼º¹Î(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 04-09 Emerald Hall B (3F) 17:15~17:30 ÁúÀÇ ÀÀ´ä ()
±³À°½Ã°£ 04-09 Diamond Hall (3F) 16:00~16:20 Á¤½Å°Ç°ÀÇÇаú Àǻ簡 ¾Æµ¿ Çд뿡 °üÇØ ¾Ë¾Æ µÎ¾î¾ß ÇÏ´Â ¹ýÀûÀÎ ºÎºÐµé ±èÈ¿¿ø(¿ï»êÀÇ´ë)
±³À°½Ã°£ 04-09 Diamond Hall (3F) 16:20~16:40 ¾Æµ¿ÇÐ´ë ¹ß°ß°ú °³ÀÔ¿¡¼ Á¤½Å°Ç°ÀÇÇаú ÀÇ»çÀÇ ¿ªÇÒ ¹è½Â¹Î(°¡ÃµÀÇ´ë)
±³À°½Ã°£ 04-09 Diamond Hall (3F) 16:40~17:00 ¾Æµ¿ Çд뿡¼ °¡ÇØÀÚ¿¡ ´ëÇÑ Á¢±Ù ±èÀÎÇâ(ÇѾçÀÇ´ë)
±³À°½Ã°£ 04-09 Diamond Hall (3F) 17:00~17:20 ÇдëÀÇ »ý¹°ÇÐ ¾çÂù¸ð(¿ø±¤ÀÇ´ë)
±³À°½Ã°£ 04-09 Diamond Hall (3F) 17:20~17:30 ÁúÀÇ ÀÀ´ä ()
±³À°½Ã°£ 04-09 Emerald Hall B (3F) 17:30~17:55 Psychopathology of AVHs: Subjective and objective aspects ±è¼¼Çö(¼¿ïÀÇ´ë)
±³À°½Ã°£ 04-09 Emerald Hall B (3F) 17:55~18:20 Neurobiology of AVHs: Neuroimaging studies ÀÌÁß¼±(¿ï»êÀÇ´ë)
±³À°½Ã°£ 04-09 Emerald Hall B (3F) 18:20~18:45 Brain stimulation for AVHs: ECT, TMS and tDCS À±Å¹(µ¿±¹ÀÇ´ë)
±³À°½Ã°£ 04-09 Emerald Hall B (3F) 18:45~19:00 ÁúÀÇ ÀÀ´ä ()
±³À°½Ã°£ 04-09 Diamond Hall (3F) 17:30~17:50 ¾Æµ¿ÇÐ´ë ¿¹¹æÀ» À§ÇÑ ±¹È¸ÀÇ ¿ªÇÒ (°¡¾È) ½ÅÇö¿µ(´õºÒ¾î ¹ÎÁÖ´ç 21´ë ±¹È¸ÀÇ¿ø)
±³À°½Ã°£ 04-09 Diamond Hall (3F) 17:50~18:10 ÀÇ·á½Ã½ºÅÛ¿¡¼ÀÇ ¾Æµ¿ÇÐ´ë ¹ß°ß°ú °³ÀÔ °û¿µÈ£(¼¿ï´ëÇб³º´¿ø ÀÀ±ÞÀÇÇаú)
±³À°½Ã°£ 04-09 Diamond Hall (3F) 18:10~18:30 ÇÇÇؾƵ¿ÀÇ Á¤½Å°úÀû Æò°¡ ¹× Ä¡·á ÀÌ¿¬Á¤(¼øõÇâÀÇ´ë)
±³À°½Ã°£ 04-09 Diamond Hall (3F) 18:30~18:50 ¾Æµ¿ÇÐ´ë °¡ÇØÀÚÀÇ °³ÀÔ°ú Æò°¡ ÀÌÇØ¿ì(¼¿ïÀÇ·á¿ø ¼¿ï±¤¿ªÁ¤½Å°Ç°¼¾ÅÍ)
±³À°½Ã°£ 04-09 Diamond Hall (3F) 18:50~19:00 ÁúÀÇ ÀÀ´ä ()
±³À°½Ã°£ 04-09 Convention Hall A+B (4F) 09:00~09:45 What we learn our ancestors and pioneers in the history of psychotherapy À̺οµ(Çѱ¹À¶¿¬±¸¿ø)
±³À°½Ã°£ 04-09 Convention Hall A (4F) 09:50~10:30 Optimising treatment outcomes in bipolar disorder Chee Ng(University of Melbourne)
±³À°½Ã°£ 04-09 Convention Hall B (4F) 09:50~10:30 Mental health of hospital workers in a world in disarray Mian-Yoon Chong(Chang Gung University & Kaohsiung Chang Gung Memorial Hospital)
±³À°½Ã°£ 04-09 Convention Hall C (4F) 09:50~10:30 WPA¡¯s mission, vision & action plans Afzal Javed(World Psychiatric Association)
ÈÞ½Ä 04-09 10:30~11:00 Coffee Break ()
±³À°½Ã°£ 04-09 Convention Hall A (4F) 11:00~11:20 Distress among surgical patients Sanjeev Sockalingam(University of Toronto)
±³À°½Ã°£ 04-09 Convention Hall A (4F) 11:20~11:40 Distress among medical patients Hochang Lee(University of Rochester Medical Center)
±³À°½Ã°£ 04-09 Convention Hall A (4F) 11:40~12:00 Distress among hospital staff ±è¼±¹Ì(Áß¾Ó´ëÇб³º´¿ø)
±³À°½Ã°£ 04-09 Convention Hall A (4F) 12:00~12:20 Distress among family members/caregivers of family ÀÌÇöÁ¤(±¹¸³¾Ï¼¾ÅÍ)
±³À°½Ã°£ 04-09 Convention Hall A (4F) 12:20~13:30 ÁúÀÇÀÀ´ä ()
±³À°½Ã°£ 04-09 Convention Hall B (4F) 11:00~11:20 Prevention of suicide and attempted suicide in Denmark Merete Nordentoft(University of Copenhagen)
±³À°½Ã°£ 04-09 Convention Hall B (4F) 11:20~11:40 The strategic research for care for suicide attempters and its social implementation in Japan Chiaki Kawanishi(Sapporo Medical University Graduate School of Medicine)
±³À°½Ã°£ 04-09 Convention Hall B (4F) 11:40~12:00 Suicide prevention action plan and post suicide attemp case management in South Korea ¹éÁ¾¿ì(°æÈñ´ëÇб³ ÀÇ°ú´ëÇÐ)
±³À°½Ã°£ 04-09 Convention Hall B (4F) 12:00~12:20 COVID-19 and mental health in South Korea ¹ÚÇѼ±(¼¿ï´ëÇб³ »çȸ°úÇдëÇÐ)
±³À°½Ã°£ 04-09 Convention Hall B (4F) 12:20~13:30 ÁúÀÇÀÀ´ä ()
±³À°½Ã°£ 04-09 Convention Hall C (4F) 11:00~11:30 Ketamine and esketamine, research to clinical practice: experience at Massachuts General Hospital Cristina Cusin(Harvard Medical School)
±³À°½Ã°£ 04-09 Convention Hall C (4F) 11:30~11:55 Neural mechanism and clinical effects of esketamine in MDD patients with suicidal ideation ÀüÈ«Áø(¼º±Õ°üÀÇ´ë »ï¼º¼¿ïº´¿ø)
±³À°½Ã°£ 04-09 Convention Hall C (4F) 11:55~12:20 Suitable patients for esketamine and reduce potential side effects in MDD patients with suicidal ideation ±è±â¿ø(Áß¾Óº¸Èƺ´¿ø)
±³À°½Ã°£ 04-09 Convention Hall C (4F) 12:20~13:30 ÁúÀÇÀÀ´ä ()
±³À°½Ã°£ 04-09 Emerald Hall A (3F) 11:00~11:20 Geriatric mental health in COVID-10 pandemic situation È«³ª·¡(ÇѸ²´ëÇб³ ¼º½Éº´¿ø)
±³À°½Ã°£ 04-09 Emerald Hall A (3F) 11:20~11:40 Effect of loneliness on the mental and physical health of old people °Àç¸í(°¡ÃµÀÇ´ë ±æº´¿ø)
±³À°½Ã°£ 04-09 Emerald Hall A (3F) 11:40~12:00 Price of a pandemic for elderly women Prabha Chandra(National Institute of Mental Health and Neurosciences)
±³À°½Ã°£ 04-09 Emerald Hall A (3F) 12:00~12:20 Consideration for geriatric population during the COVID 19 Loneliness ½Åö¹Î(°í·Á´ëÇб³¾È»êº´¿ø)
±³À°½Ã°£ 04-09 Emerald Hall A (3F) 12:20~13:30 ÁúÀÇÀÀ´ä ()
±³À°½Ã°£ 04-09 Convention Hall A+B (4F) 12:30~13:30 The optimal treatment option to break the cycle of relapse in schizophrenia ¿À»óÈÆ(ÀÇÁ¤ºÎÀ»Áö´ëÇб³º´¿ø)
±³À°½Ã°£ 04-09 Convention Hall A+B (4F) 12:30~13:30 Reliable long-term management that prevents recurrences and preserves functioning in bipolar disorder Á¶¼ºÁØ(¼º±Õ°üÀÇ´ë °ºÏ»ï¼ºº´¿ø)
±³À°½Ã°£ 04-09 Emerald Hall A+B (3F) 12:30~13:30 Antipsychotics & suicide risk mitigation in mood disorder ¹éÁ¾¿ì(°æÈñ´ëÇб³ ÀÇ°ú´ëÇÐ)
ÈÞ½Ä 04-09 13:30~14:00 Break ()
±³À°½Ã°£ 04-09 Convention Hall A (4F) 14:00~14:20 Autism spectrum disorder: early detection and screening ±è¿¹´Ï(µ¿±¹´ëÇб³ ÀÇ°ú´ëÇÐ)
±³À°½Ã°£ 04-09 Convention Hall A (4F) 14:20~14:40 ADHD: early detection and screening È«¹ÎÇÏ(ÇѾç´ëÇб³ ÀÇ°ú´ëÇÐ)
±³À°½Ã°£ 04-09 Convention Hall A (4F) 14:40~15:00 Suicide: Screening, early detection and prevention ±Ç¿ë½Ç(°¡Å縯ÀÇ´ë ÀÇÁ¤ºÎ¼º¸ðº´¿ø)
±³À°½Ã°£ 04-09 Convention Hall A (4F) 15:00~15:20 Pediatric bipolar disorder: Early detection and screening Mani Pavuluri(Brain and Wellness Institute)
±³À°½Ã°£ 04-09 Convention Hall A (4F) 15:20~15:30 ÁúÀÇÀÀ´ä (N/A)
±³À°½Ã°£ 04-09 Convention Hall B (4F) 14:00~14:20 Overview of polypharmacy in Asian counteries based on REAP survey Chay Hoon Tan(Yong Loo Lin School of Medicine)
±³À°½Ã°£ 04-09 Convention Hall B (4F) 14:20~14:40 Network-based analyses of patterns of psychotropic medication uses in Asian patients with schizophrenia ¹Ú¼±Ã¶()
±³À°½Ã°£ 04-09 Convention Hall B (4F) 14:40~15:00 How to face and combat polypharmacy-based clinical practice: Case reports an early-career psychiatrist Muneomi Kayo(Kyushu University)
±³À°½Ã°£ 04-09 Convention Hall B (4F) 15:00~15:20 A call for a rational polypharmacy policy: Based on an international survey on psychiatrists¡¯ decision-making Yukako Nakagami(Kyoto University)
±³À°½Ã°£ 04-09 Convention Hall B (4F) 15:20~15:30 ÁúÀÇÀÀ´ä Norman Satorius(Association for the Improvement of Mental Health Programmes)
±³À°½Ã°£ 04-09 Convention Hall C (4F) 14:00~14:20 Screening and assessment for hikikomori and other forms of social disconnection Alan Teo(Oregon Health & Science University)
±³À°½Ã°£ 04-09 Convention Hall C (4F) 14:20~14:40 Current status of hikikomori in Japan Motohiro Sakai(University of Miyazaki)
±³À°½Ã°£ 04-09 Convention Hall C (4F) 14:40~15:00 Psychiatric conditions that co-occur with hikikomori Takahiro Kato(Kyushu University)
±³À°½Ã°£ 04-09 Convention Hall C (4F) 15:00~15:20 Hikikomori outside Japan ÃÖÅ¿µ(´ë±¸°¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ)
±³À°½Ã°£ 04-09 Convention Hall C (4F) 15:20~15:30 ÁúÀÇÀÀ´ä N/A(N/A)
±³À°½Ã°£ 04-09 Emerald Hall A (3F) 14:00~14:20 Quarantine & trauma: Mental health implications on a fragile balance between human right and public safety ÀÌÁ¤Çö(±¹¸³Á¤½Å°Ç°¼¾ÅÍ)
±³À°½Ã°£ 04-09 Emerald Hall A (3F) 14:20~14:40 Disaster, social measures and mental health: What can we learn history ±èÈ£(°æÀα³À°´ëÇб³)
±³À°½Ã°£ 04-09 Emerald Hall A (3F) 14:40~15:00 Anthropological perspective on pandemic, human behavior and mental health ¹ÚÇѼ±(¼¿ï´ëÇб³ »çȸ°úÇдëÇÐ)
±³À°½Ã°£ 04-09 Emerald Hall A (3F) 15:00~15:20 Understanding minds of people living in the era of pandemic: the perspective of Collective unconscious À̳ª¹Ì(¼¿ï´ëÇб³º´¿ø)
±³À°½Ã°£ 04-09 Emerald Hall A (3F) 15:20~15:30 ÁúÀÇÀÀ´ä ()
ÈÞ½Ä 04-09 15:30~16:00 Coffee Break ()
±³À°½Ã°£ 04-09 Convention Hall A (4F) 16:00~16:20 The neural mechanisms of plasticity in semantic cognition: Variable neuro-displacement hypothesis Á¤Á¦¿µ(University of Nottingham)
±³À°½Ã°£ 04-09 Convention Hall A (4F) 16:20~16:40 Neuroinflammation and neurodegeneration in depression ÇѱԸ¸(°í·ÁÀÇ´ë ¾È¾Ïº´¿ø)
±³À°½Ã°£ 04-09 Convention Hall A (4F) 16:40~17:00 Exploring the neurobiology of OCD through the concept of thought-action fusion ÀÌ»ó¿ø(Ä¥°î°æºÏ´ëÇб³º´¿ø)
±³À°½Ã°£ 04-09 Convention Hall A (4F) 17:00~17:20 Decreased cortical gryification in patients with bipolar disorder ÃÖ°ü¿ì(°í·ÁÀÇ´ë ¾È¾Ïº´¿ø)
±³À°½Ã°£ 04-09 Convention Hall A (4F) 17:20~17:30 ÁúÀÇÀÀ´ä ()
±³À°½Ã°£ 04-09 Convention Hall B (4F) 16:00~16:20 Effects of infectious disease – Related psychological stress on severe mental illness ½É¹Î¿µ(±¹¸³Á¤½Å°Ç°¼¾ÅÍ ±¹°¡Æ®¶ó¿ì¸¶¼¾ÅÍ)
±³À°½Ã°£ 04-09 Convention Hall B (4F) 16:20~16:40 Strategies of infection control in psychiatric wards during biological disasters ÀüÁØ¿µ(±¹¸³¾Ï¼¾ÅÍ)
±³À°½Ã°£ 04-09 Convention Hall B (4F) 16:40~17:00 The outcomes of the COVID-19 infection among patients with psychiatric diagnosis ÀÌÇØ¿ì(¼¿ïÀÇ·á¿ø)
±³À°½Ã°£ 04-09 Convention Hall B (4F) 17:00~17:20 Consideration for community mental health services of severe mental illness during the COVID-19 pandemic ¼È¿¬(¼¿ï´ë햑±³º´¿ø)
±³À°½Ã°£ 04-09 Convention Hall B (4F) 17:20~17:30 ÁúÀÇÀÀ´ä ()
±³À°½Ã°£ 04-09 Convention Hall C (4F) 16:00~16:20 The factor structure of EPS using the DIEPSS in patients with schizophrenia: Results the 2016 REAP AP-4 study Chika Kubota(National Center of Neurology and Psychiatry)
±³À°½Ã°£ 04-09 Convention Hall C (4F) 16:20~16:40 Profile antipsychotics among schizophrenia patient in Indonesia: results the Research on Asia Psychotropic Preion (REAP) studies Andi Jayalangkara Tanra(Hasanuddin University Hospital)
±³À°½Ã°£ 04-09 Convention Hall C (4F) 16:40~17:00 Brief introduction on preion pattern and clinical characteristics of patients with mood stabilizer-induced cognitive side effects: Findings the REAP-BD survey in Korea ±è±â¿ø(Áß¾Óº¸Èƺ´¿ø)
±³À°½Ã°£ 04-09 Convention Hall C (4F) 17:00~17:20 Adverse events related to antipsychotic medications in Asia: Trend analysis REAP-AP 1-4 Kok Yoon Chee(Kuala Lumpur Hospital)
±³À°½Ã°£ 04-09 Convention Hall C (4F) 17:00~17:20 Side effects of psychotropic agents in Asia Sandeep Grover(Post Graduate Institute of Medical Education and Research)
±³À°½Ã°£ 04-09 Convention Hall C (4F) 17:20~17:30 Åä·Ð Chay Hoon Tan(Yong Loo Lin School of Medicine)
±³À°½Ã°£ 04-09 Emerald Hall A (3F) 16:00~16:20 Digital healthcare for obsessive-compulsive disorder ÇÑ´öÇö(Áß¾Ó´ëÇб³ ÀÇ°ú´ëÇÐ)
±³À°½Ã°£ 04-09 Emerald Hall A (3F) 14:30~14:50 Digital healthcare for eating behavior ÃÖÇüÁø(¼¿ï´ëÇб³ ÀÇ°ú´ëÇÐ)
±³À°½Ã°£ 04-09 Emerald Hall A (3F) 16:40~17:00 Digital healthcare for depression phenotype screening ÀÌÁ¤Àç(´Ü±¹´ëÇб³ ÀÇ°ú´ëÇÐ)
±³À°½Ã°£ 04-09 Emerald Hall A (3F) 17:00~17:20 Digital healthcare for memory training ÀÌÁØ¿µ(¼¿ïƯº°½Ãº¸¶ó¸Åº´¿ø)
±³À°½Ã°£ 04-09 Emerald Hall A (3F) 17:20~17:30 ÁúÀÇÀÀ´ä ()
±³À°½Ã°£ 04-09 Convention Hall B (4F) 17:30~17:50 Effect of low-intensity focused ultrasound stimulation in patients with major depressive disorder: Interim analysis of an exploratory clinical trial ¼®Á¤È£(¿¬¼¼ÀÇ´ë °³²¼¼ºê¶õ½ºº´¿ø)
±³À°½Ã°£ 04-09 Convention Hall B (4F) 17:50~18:10 Differences in psychological difficulties and well-being of middle and high school students amidst COVID-19 pandemic based on their involvement in organized activities. Nabilah Amalina Rozi(Research of Community Mental Health Initiatives Faculty of Psychology Universitas Indonesia)
±³À°½Ã°£ 04-09 Convention Hall B (4F) 18:10~18:30 Ethnic difference in pharmacokinetic of antipsychotics SHIH-KU Lin(Chang Gung Memorial Hospital LinKo)
±³À°½Ã°£ 04-09 Convention Hall C (4F) 17:30~17:42 Psychotropic drug preion and psychosocial intervention in university students during the crisis of suicide copycat in 2019: a 6-month follow-up study Chonnakarn Jatchavala(Prince of Songkla University)
±³À°½Ã°£ 04-09 Convention Hall C (4F) 17:42~17:54 Development and validation of deep learning-based software using brain magnetic resonance imaging for Alzheimer ¹èÁ¾ºó(ºÐ´ç¼¿ï´ëÇб³º´¿ø)
±³À°½Ã°£ 04-09 Convention Hall C (4F) 17:54~18:06 Long-term benefits of mindfulness on white matter tracts underlying the cortical midline structures in panic disorder ÀÌÁØÈ£(ºÐ´çÂ÷º´¿ø)
±³À°½Ã°£ 04-09 Convention Hall C (4F) 18:06~18:18 Structural brain alterations in cortical thickness, volume and surface area in patients with bipolar types I and II ¿ìÀ±¹Ì(°í·ÁÀÇ´ë ¾È¾Ïº´¿ø)
±³À°½Ã°£ 04-09 Convention Hall C (4F) 18:18~18:30 The efficacy of computerized cognitive training program in preschool children with and without developmental disabilities ÀÌÅ¿±(¿ï»êÀÇ´ë ¼¿ï¾Æ»êº´¿ø)
±³À°½Ã°£ 04-09 Emerald Hall A (3F) 17:30~17:42 Life and psychological impacts of COVID-19, risk factors for post-traumatic stress, depression, and anxiety of the elderly at long-term care centers Maytinee Srifuengfung(Faculty of Medicine Siriraj Hospital Mahidol University)
±³À°½Ã°£ 04-09 Emerald Hall A (3F) 17:42~17:54 Alteration of surface area and cortical thickness in drug-naïve adults with major depressive disorder ÀÌÁö¼ö(°í·ÁÀÇ´ë ¾È¾Ïº´¿ø)
±³À°½Ã°£ 04-09 Emerald Hall A (3F) 17:54~18:06 The psychological impact of COVID-19 pandemic in quarantine population ±è½Âºó(´ë±¸°¡Å縯´ëÇб³º´¿ø)
±³À°½Ã°£ 04-09 Emerald Hall A (3F) 18:06~18:18 The perceived barrier to visiting psychiatrists in Korea: Findings by text mining analysis on social media big data ¼È¿¬(¼¿ï´ë햑±³º´¿ø)
±³À°½Ã°£ 04-09 Emerald Hall A (3F) 18:18~18:30 Correlation between smart phone app use patterns and athlete performance of professional golfers Á¤½Â¾Æ(Áß¾Ó´ëÇб³º´¿ø)